Literature DB >> 23265903

Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity.

María V Buchieri1, Leonardo E Riafrecha, Oscar M Rodríguez, Daniela Vullo, Héctor R Morbidoni, Claudiu T Supuran, Pedro A Colinas.   

Abstract

A small series of C-cinnamoyl glycoside containing the phenol moiety was tested for the inhibition of the three Mycobacterium tuberculosis β-carbonic anhydrases (CAs, EC 4.2.1.1) with activities in the low micromolar range detected. The compounds were also tested for the inhibition of growth of M. tuberculosis H(37)Rv strain, leading to the identification of (E)-1-(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl)-4-(3-hydroxyphenyl)but-3-en-2-one (1) as the first carbonic anhydrase inhibitor with anti-tubercular activity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23265903     DOI: 10.1016/j.bmcl.2012.11.085

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Designing of phenol-based β-carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach.

Authors:  Shahzaib Ahamad; Md Imtaiyaz Hassan; Neeraja Dwivedi
Journal:  3 Biotech       Date:  2018-05-14       Impact factor: 2.406

Review 2.  Small Molecules That Sabotage Bacterial Virulence.

Authors:  Benjamin K Johnson; Robert B Abramovitch
Journal:  Trends Pharmacol Sci       Date:  2017-02-14       Impact factor: 14.819

3.  Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents.

Authors:  Mohamed Nabil Abd Al Moaty; El Sayed Helmy El Ashry; Laila Fathy Awad; Nihal Ahmed Ibrahim; Marwa Muhammad Abu-Serie; Assem Barakat; Mezna Saleh Altowyan; Mohamed Teleb
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

Review 4.  Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.

Authors:  Ashok Aspatwar; Jean-Yves Winum; Fabrizio Carta; Claudiu T Supuran; Milka Hammaren; Mataleena Parikka; Seppo Parkkila
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

5.  An overview of carbohydrate-based carbonic anhydrase inhibitors.

Authors:  Doretta Cuffaro; Elisa Nuti; Armando Rossello
Journal:  J Enzyme Inhib Med Chem       Date:  2020-10-20       Impact factor: 5.051

6.  Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis.

Authors:  Reza Zolfaghari Emameh; Marianne Kuuslahti; Daniela Vullo; Harlan R Barker; Claudiu T Supuran; Seppo Parkkila
Journal:  Parasit Vectors       Date:  2015-09-18       Impact factor: 3.876

Review 7.  Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs.

Authors:  Ashok Aspatwar; Visvaldas Kairys; Sangeetha Rala; Mataleena Parikka; Murat Bozdag; Fabrizio Carta; Claudiu T Supuran; Seppo Parkkila
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.